Differential development of umbilical and systemic arteries. I. ANG II receptor subtype expression

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 274, Issue 3 43-3, 1998, Pages

  Kaiser, Jeffrey R ^a   Cox, Blair E ^a   Roy, Timothy A ^a   Rosenfeld, Charles R ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Blood flow; Fetal sheep; Plasma renin activity; Vascular smooth muscle

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 2 ETHYL 5,7 DIMETHYL 3 [4 [2 (2H TETRAZOL 5 YL)PHENYL]BENZYL]IMIDAZO[4,5 B]PYRIDINE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II [1 SARCOSINE 8 ISOLEUCINE]; ANGIOTENSIN RECEPTOR ANTAGONIST; RECEPTOR SUBTYPE; RENIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY RESISTANCE; ARTICLE; CONTROLLED STUDY; FEMORAL ARTERY; FETUS; MEAN ARTERIAL PRESSURE; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; SHEEP; UMBILICAL ARTERY; UMBILICAL CORD BLOOD FLOW; VASCULAR RESISTANCE;

EID: 0031897617     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1998.274.3.r797     Document Type: Article

References (47)

1. Adamson, S. L., R. J. Morrow, S. B. Bull, and B. L. Langille. Vasomotor responses of the umbilical circulation in fetal sheep. Am. J. Physiol. 256 (Regulatory Integrative Comp. Physiol. 25): R1056-R1062, 1989.
2. Anderson, D. F., A. Barbera, and J. J. Faber. Substantial reductions in blood pressure after bilateral nephrectomy in fetal sheep. Am. J. Physiol. 266 (Heart Circ. Physiol. 35): H17-H20, 1994.
3. Assali, N. S., C. R. Brinkman III, J. R. Woods, Jr., A. Dandavino, and B. Nuwayhid. Development of neurohumoral control of fetal, neonatal, and adult cardiovascular functions. Am. J. Obstet. Gynecol. 129: 748-759, 1977.
4. Bottari, S. P., M. de Gasparo, U. M. Steckelings, and N. R. Levens. Angiotensin II receptor subtypes: characterization, signaling mechanisms, and possible physiological implications. Front. Neuroendocrinol. 14: 123-171, 1993.
5. Boyle, D. W., K. Hirst, G. O. Zerbe, G. Meschia, and R. B. Wilkening. Fetal hind limb oxygen consumption and blood flow during acute graded hypoxia. Pediatr. Res. 28: 94-100, 1990.
6. Campbell, W. B., and E. K. Jackson. Modulation of adrenergic transmission by angiotensins in the perfused rat mesentery. Am. J. Physiol. 236 (Heart Circ. Physiol. 5): H211-H217, 1979.
7. Chiu, A. T., W. F. Herblin, D. E. McCall, R. J. Ardecky, D. J. Carini, J. V. Duncia, L. J. Pease, P. C. Wong, R. R. Wexler, A. L. Johnson, and P. B. M. W. M. Timmermans. Identification of angiotensm II receptor subtypes. Biochem. Biophys. Res. Commun. 165: 196-203, 1989.
8. Clark, K. E., G. L. Irion, and C. E. Mack. Differential responses of uterine and umbilical vasculatures to angiotensin II and norepinephrine. Am. J. Physiol. 259 (Heart Circ. Physiol. 28): H197-H203, 1990.
9. Cox, B. E., M. A. Ipson, P. W. Shaul, K. E. Kamm, and C. R. Rosenfeld. Myometrial angiotensin II receptor subtypes change during ovine pregnancy. J. Clin. Invest. 92: 2240-2248, 1993.
10. Cox, B. E., C. R. Rosenfeld, J. E. Kalinyak, R. R. Magness, and P. W. Shaul. Tissue-specific expression of vascular smooth muscle angiotensin II receptor subtypes during ovine pregnancy. Am. J. Physiol. 271 (Heart Circ. Physiol. 40): H212-H221, 1996.
11. Cox, B. E., C. E. Williams, and C. R. Rosenfeld. Ontogeny of vascular smooth muscle (VSM) angiotensin II (ANG II) receptor subtype expression in fetal and newborn sheep (Abstract). Proc. 68th Sci. Sess. Am. Heart Assoc., Anaheim, CA, 1995, p. 1446.
12. Cox, B. E., C. E. Williams, T. A. Roy, and C. R. Rosenfeld. Angiotensin II does not directly vasoconstrict the uterine circulation in pregnant and nonpregnant ewes (Abstract). J. Soc. Gynecol. Investig. 3: 284A, 1996.
13. Cox, B. E., R. A. Word, and C. R. Rosenfeld. Angiotensin II receptor characteristics and subtype expression in uterine arteries and myometrium during pregnancy. J. Clin. Endocrinol. Metab. 81: 49-58, 1996.
14. Dawes, G. S. The umbilical circulation. Am. J. Obstet. Gynecol. 84: 1634-1648, 1962.
15. 2 in human myometrium during pregnancy. Regul. Pept. 53: 39-45, 1994.
16. Dudley, D. T., R. L. Panek, T. C. Major, G. H. Lu, R. F. Bruns, B. A. Klinkefus, J. C. Hodges, and R. E. Weishaar. Subclasses of angiotensin II binding sites and their functional significance. Mol. Pharmacol 38: 370-377, 1990.
17. Feuillan, P. P., M. A. Millan, and G. Aguilera. Angiotensin II binding sites in the rat fetus: characterization of receptor subtypes and interaction with guanyl nucleotides. Regul. Pept. 44: 159-169, 1993.
18. 2 receptors in the developing rat fetus. J. Clin. Invest. 88: 921-933, 1991.
19. Harris, W. H., and G. R. Van Petten. Development of cardiovascular responses to noradrenaline, adrenaline, normetanephrine, and metanephrine in the unanesthetized fetus. Can. J. Physiol. Pharmacol. 57: 242-250, 1979.
20. Iwamoto, H. S., and A. M. Rudolph. Effects of endogenous angiotensin II on the fetal circulation. J. Dev. Physiol. (Eynsham) 1: 283-293, 1979.
21. Iwamoto, H. S., and A. M. Rudolph. Effects of angiotensin II on the blood flow and its distribution in fetal lambs. Circ. Res. 48: 183-189, 1981.
22. Iwamoto, H. S., and A. M. Rudolph. Role of renin-angiotensin system in response to hemorrhage in fetal sheep. Am. J. Physiol. 240 (Heart Circ. Physiol. 9): H848-H854, 1981.
23. Keeton, T. K., and W. B. Campbell. The pharmacologic alteration of renin release. Pharmacol. Rev. 32: 81-227, 1980.
24. Kingdom, J. C. P., J. McQueen, J. M. C. Connell, and M. J. Whittle. Fetal angiotensin II levels and vascular (type 1) angiotensin receptors in pregnancies complicated by intrauterine growth retardation. Br. J. Obstet. Gynaecol. 100: 476-482, 1993.
25. 1) vascular binding sites in human placentae from normal-term, preeclamptic and growth retarded pregnancies. J. Pharmacol. Exp. Ther. 271: 1007-1015, 1994.
26. Lumbers, E. R., and A. D. Stevens. The effects of furosemide, saralasin and hypotension on fetal plasma renin activity and on fetal renal function. J. Physiol. (Lond.) 393: 479-490, 1987.
27. Mackanjee, H. R., P. W. Shaul, R. R. Magness, and C. R. Rosenfeld. Angiotensin II vascular smooth-muscle receptors are not down-regulated in near-term pregnant sheep. Am. J. Obstet. Gynecol. 165: 1641-1648, 1991.
28. McDonald, K. M., S. Taher, G. Aisenbrey, A. de Torrente, and R. W. Schrier. Effect of angiotensin II and angiotensin II inhibitor on renin secretion in the dog. Am. J. Physiol. 228: 1562-1567, 1975.
29. McPherson, G. A. Analysis of radioligand binding experiments: a collection of computer programs for the IBM PC. J. Pharmacol. Toxicol. Methods 14: 213-228, 1985.
30. Munson, P. J., and D. Rodbard. LIGAND: a versatile computerized approach for the characterization of ligand-binding systems. Anal. Biochem. 107: 220-239, 1980.
31. Peeters, L. L. H., R. E. Sheldon, M. D. Jones, Jr., E. L. Makowski, and G. Meschia. Blood flow to fetal organs as a function of arterial oxygen content. Am. J. Obstet. Gynecol. 135: 637-646, 1979.
32. Rankin, J. H., and T. M. Phernetton. Alpha and angiotensin receptor tone in the near-term sheep fetus. Proc. Soc. Exp. Biol. Med. 158: 166-169, 1978.
33. 2) during fetal life in sheep. Pediatr. Res. 38: 896-904, 1995.
34. Robillard, J. E., D. N. Weismann, R. A. Gomez, N. A. Ayres, W. J. Lawton, and D. E. VanOrden. Renal and adrenal responses to converting-enzyme inhibition in fetal and newborn life. Am. J. Physiol. 244 (Regulatory Integrative Comp. Physiol. 13): R249-R256, 1983.
35. Rosenfeld, C. R., B. E. Cox, R. R. Magness, and P. W. Shaul. Ontogeny of angiotensin II vascular smooth muscle receptors in ovine fetal aorta and placental and uterine arteries. Am. J. Obstet. Gynecol. 168: 1562-1569, 1993.
36. Rosenfeld, C. R., A. Gresores, T. A. Roy, and R. R. Magness. Comparison of ANG II in fetal and pregnant sheep: metabolic clearance and vascular sensitivity. Am. J. Physiol. 268 (Endocrinol. Metab. 31): E237-E247, 1995.
37. Scroop, G. C., B. Stankewytsch-Janusch, and J. D. Marker. Renin-angiotensin and autonomic mechanisms in cardiovascular homeostasis during haemorrhage in fetal and neonatal sheep. J. Dev. Physiol. (Eynsham) 18: 25-33, 1992.
38. Siegl, P. S., R. S. Chang, N. B. Mantlo, P. K. Chakravarty, D. L. Ondeyka, W. J. Greenlee, A. A. Patchett, C. S. Sweet, and V. J. Lotti. In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist. J. Pharmacol. Exp. Ther. 262: 139-144, 1992.
39. Stevenson, K. M., K. J. Gibson, and E. R. Lumbers. Comparison of the transplacental transfer of enalapril, captopril and losartan in sheep. Br. J. Pharmacol. 114: 1495-1501, 1995.
40. 2 receptors regulate cerebral blood flow in rats. Neuroreport 3: 703-704, 1992.
41. 2 angiotensin II receptors in rat anterior cerebral arteries. Am. J. Physiol. 261 (Heart Circ. Physiol. 30): H667-H670, 1991.
42. Viswanathan, M., K. Tsutsumi, F. M. Correa, J. M. Saavedra. Changes in expression of angiotensin receptor subtypes in the rat aorta during development. Biochem. Biophys. Res. Commun. 179: 1361-1367, 1991.
43. Whitebread, S., M. Mele, B. Kamber, and M. de Gasparo. Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochem. Biophys. Res. Commun. 163: 284-291, 1989.
44. Wilkening, R. B., D. W. Boyle, and G. Meschia. Measurement of blood flow and oxygen consumption in the pelvic limb of fetal sheep. Proc. Soc. Exp. Biol. Med. 187: 498-505, 1988.
45. Wilkening, R. B., and G. Meschia. Fetal oxygen uptake, oxygenation, and acid-base balance as a function of uterine blood flow. Am. J. Physiol. 244 (Heart Circ. Physiol. 13): H749-H755, 1983.
46. Wong, P. C., S. D. Hart, A. M. Zaspel, A. T. Chiu, R. J. Ardecky, R. D. Smith, and P. B. M. W. M. Timmermans. Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2). J. Pharmacol. Exp. Ther. 255: 584-592, 1990.
47. Yoshimura, T., R. R. Magness, and C. R. Rosenfeld. Angiotensin II and α-agonist. I. Responses of ovine fetoplacental vasculature. Am. J. Physiol. 259 (Heart Circ. Physiol. 28): H464-H472, 1990.